Holen Sie sich die Stockscreener-App
23.75
3.44%
0.79
Schlusskurs vom Vortag:
$22.96
Offen:
$23.19
24-Stunden-Volumen:
146.21K
Relative Volume:
1.09
Marktkapitalisierung:
$1.24B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.02%
1M Leistung:
-7.59%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$22.95
$24.02
1-Wochen-Bereich:
$22.77
$25.62
52-Wochen-Spanne:
$20.00
$26.15
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Vergleichen Sie KMTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
23.75 | 1.24B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
529.42 | 184.44B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
168.78 | 58.89B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
98.30 | 46.96B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
239.95 | 34.59B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.30 | 16.16B | 3.90B | 392.30M | 288.10M | 1.95 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Kestra Medical Technologies to Participate in Upcoming Investor Conferences - GlobeNewswire
Digital Health Leader Kestra Medical Secures Speaking Slots at Two Major Healthcare Conferences - Stock Titan
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 - GlobeNewswire
Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Target Price at $27.50 - Defense World
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 - The Manila Times
Kestra Medical Technologies to Showcase Innovation in - GlobeNewswire
Kestra Medical Technologies, Ltd. to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery At Heart Rhythm 2025 - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 12-Month HighShould You Buy? - MarketBeat
The Goldman Sachs Group Has Lowered Expectations for Kestra Medical Technologies (NASDAQ:KMTS) Stock Price - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down Following Weak Earnings - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 4.3% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Posts Quarterly Earnings Results, Misses Expectations By $0.61 EPS - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss - The AM Reporter
Kestra Medical price target lowered to $23 from $24 at Goldman Sachs - TipRanks
Piper Sandler maintains $27 target on Kestra Medical stock By Investing.com - Investing.com South Africa
Piper Sandler maintains $27 target on Kestra Medical stock - Investing.com Australia
Kestra Medical Technologies revenue jumps 82% to USD 15.1M in Q3 FY25 - Medical Buyer
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 4.3% Following Weak Earnings - Defense World
Kestra Medical Technologies Reports Strong Q3 Growth - TipRanks
Kestra Medical Technologies Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Kestra Medical Q3 FY2025 sees revenue surge By Investing.com - Investing.com India
Earnings call transcript: Kestra Medical Q3 FY2025 sees revenue surge - Investing.com Australia
Kestra Medical Tech Reports Third Quarter Fiscal 2025 Financial Results - marketscreener.com
Kestra Medical reports Q3 EPS ($1.25) vs. ($1.18) last year - TipRanks
Earnings Flash (KMTS) Kestra Medical Technologies Posts Q3 Revenue $15.1M, vs. FactSet Est of $15.1M - marketscreener.com
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewswire
Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy - TipRanks
Kestra Medical Technologies, Ltd.'s Quiet Period To End on April 15th (NASDAQ:KMTS) - MarketBeat
Kestra Medical Technologies, Ltd.’s Quiet Period To End on April 15th (NASDAQ:KMTS) - The AM Reporter
Kestra Medical Technologies, Ltd.’s Quiet Period To Expire on April 15th (NASDAQ:KMTS) - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 1-Year HighShould You Buy? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.67 Average Price Target from Brokerages - The AM Reporter
Kestra Medical Technologies (NASDAQ:KMTS) Earns Overweight Rating from Analysts at Piper Sandler - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by The Goldman Sachs Group - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.67 Average Target Price from Analysts - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Wells Fargo & Company - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading 2.5% HigherTime to Buy? - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Stifel Nicolaus - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Wolfe Research - MarketBeat
Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors - Yahoo Finance
Analysts Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.67 - Defense World
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14 - The Manila Times
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Es liegen keine Finanzdaten für Kestra Medical Technologies Ltd (KMTS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.05%
5.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):